Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study

Zilucoplan was well-tolerated and effective in most patients with AChR-positive gMG. A clinical meaningful effect was reported since the first week and was sustained after 24 weeks. Further studies are needed to confirm these preliminary real-life data.

Authors

Institutions

Publication Details

Journal
Journal of the Neurological Sciences
Published
2025-11-24
DOI
https://doi.org/10.1016/j.jns.2025.125671
Citations
7
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
9.72
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study

Raffaele Iorio, Francesco Tuccillo, Luca Codeluppi, Elena Rossini et al.
7 citations
Journal of the Neurological Sciences
Myasthenia Gravis and Thymoma
9.72
article

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study

Raffaele Iorio, Francesco Tuccillo, Luca Codeluppi, Elena Rossini, Claudia Vinciguerra, Fiammetta Biasini, Paolo Emilio Alboini, Paolo Alonge, Rita Frangiamore, Carlo Antozzi, Laura Fionda, Alvino Bisecco, Fiammetta Vanoli, Silvia Bonanno, Martina Verza, Francesco Saccà, Stefania Morino, Filippo Brighina, Valentina Damato, Lucía Florio, Giulia D’Alvano, Francesco Habetswallner, Melania Guida, Carmen Erra, Sofia Helena Valente de Lemos‐Marini, Lorenzo Maggi, Vincenzo Di Stefano, Michelangelo Maestri Tassoni, Nicasio Rini, Alessio Sarnataro, Alessia Pugliese, Martina Marini, Liliana Bevilacqua, Pietro Luppino
article en
7 citations

Abstract

Zilucoplan was well-tolerated and effective in most patients with AChR-positive gMG. A clinical meaningful effect was reported since the first week and was sustained after 24 weeks. Further studies are needed to confirm these preliminary real-life data.

Journal of the Neurological SciencesVol. 479
Università Cattolica del Sacro Cuore (IT), University of Messina (IT), University of Salerno (IT), University of Campania "Luigi Vanvitelli" (IT), Casa Sollievo della Sofferenza (IT), Agostino Gemelli University Polyclinic (IT), Ospedale Antonio Cardarelli (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), CTO Andrea Alesini (IT), Federico II University Hospital (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), Azienda Ospedaliera Universitaria Pisana (IT), University of Florence (IT), Sapienza University of Rome (IT), University of Palermo (IT)
Openalex Percentile: Top 2%
Myasthenia Gravis and Thymoma
9.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.